Norges Bank Lexicon Pharmaceuticals, Inc. Transaction History

Norges Bank

$634 Trillion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.06 - $2.33 $87,874 - $193,157	-82,900 Closed	0 $0
Q3 2022 Nov 13, 2023	BUY	$1.94 - $3.43 $160,826 - $284,347	82,900 New	82,900 $198,000
Q3 2021 Nov 05, 2021	SELL	$3.38 - $5.35 $1.16 Million - $1.84 Million	-344,600 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$4.12 - $5.87 $1.42 Million - $2.02 Million	344,600 New	344,600 $1.58 Million
Q1 2020 May 08, 2020	SELL	$1.8 - $4.28 $38,572 - $91,716	-21,429 Closed	0 $0

Q4 2019 Mar 03, 2020	BUY	$3.16 - $5.15 $67,715 - $110,359	21,429 New	21,429 $89,000
Q4 2019 Feb 12, 2020	SELL	$3.16 - $5.15 $478,256 - $779,437	-151,347 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$1.2 - $6.66 $181,616 - $1.01 Million	151,347 New	151,347 $456,000
Q3 2019 Nov 08, 2019	SELL	$1.2 - $6.66 $181,616 - $1.01 Million	-151,347 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$5.35 - $7.11 $809,706 - $1.08 Million	151,347 New	151,347 $952,000
Q2 2019 Aug 09, 2019	SELL	$5.35 - $7.11 $809,706 - $1.08 Million	-151,347 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$6.15 - $10.51 $930,784 - $1.59 Million	151,347 New	151,347 $1.01 Million
Q4 2018 Feb 08, 2019	SELL	$6.15 - $10.51 $1.64 Million - $2.8 Million	-266,463 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$10.32 - $13.06 $2.75 Million - $3.48 Million	266,463 New	266,463 $2.84 Million
Q3 2018 Nov 09, 2018	SELL	$10.32 - $13.06 $2.75 Million - $3.48 Million	-266,463 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$7.8 - $13.69 $2.08 Million - $3.65 Million	266,463 New	266,463 $3.2 Million
Q2 2018 Jul 23, 2018	SELL	$7.8 - $13.69 $2.08 Million - $3.65 Million	-266,463 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$7.86 - $11.39 $2.09 Million - $3.04 Million	266,463 New	266,463 $2.28 Million
Q1 2018 May 09, 2018	SELL	$7.86 - $11.39 $2.09 Million - $3.04 Million	-266,463 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$8.77 - $12.28 $2.34 Million - $3.27 Million	266,463 New	266,463 $2.63 Million
Q4 2017 Feb 09, 2018	SELL	$8.77 - $12.28 $2.34 Million - $3.27 Million	-266,463 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$12.17 - $16.3 $3.24 Million - $4.34 Million	266,463 New	266,463 $3.28 Million
Q3 2017 Nov 07, 2017	SELL	$12.17 - $16.3 $13.5 Million - $18.1 Million	-1,111,306 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-37,173 Reduced 3.24%	1,111,306 $18.3 Million
Q1 2017 May 11, 2018	BUY	N/A	291,564 Added 34.02%	1,148,479 $16.5 Million
Q3 2016 Nov 13, 2017	BUY	N/A	856,915	856,915 $0

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

Artal Group S.A. Luxembourg, N4

118M
Shares

$188 Million
15.21% of portfolio
Black Rock Inc. New York, NY

7.69M
Shares

$12.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.4M
Shares

$10.2 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.54M
Shares

$5.67 Million
0.19% of portfolio
Geode Capital Management, LLC Boston, MA

2.39M
Shares

$3.82 Million
0.0% of portfolio

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account